Roboligent Selected for $1.8MM STTR Phase II Contract by AFWERX
Roboligent, cutting-edge robotics company dedicated to designing precise robots that work seamlessly alongside humans announces it has been selected by AFWERX for a STTR Phase II contract in the amount of $1.8MM focused on Advanced Robotic-Assisted and Customized Rehabilitation Technology to address the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on September 16, 2024, Roboligent will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. “We are honored to have been selected for the second phase of this project, following our success in the first round,” said Roboligent’s CEO Dr. Bongsu Kim. “Our human-interactive rehabilitation robots have the potential to significantly improve the quality of care for the Air Force Medical Service.” “We are glad to collaborate with AFWERX and researchers at the Human Centered Robotics laboratory at the University of Texas to develop advanced rehabilitation control policies using supervised machine learning techniques.” The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. About Roboligent Roboligent is a cutting-edge robotics company dedicated to designing precise robots that work seamlessly alongside humans. Our robots are equipped with advanced force-controlled technology, ensuring gentle and adaptable interactions in any environment. Our vision is to enhance productivity and deliver meaningful societal benefits through the widespread adoption of our advanced robotic technology. About AFRL The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit afresearchlab.com About AFWERX As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 325 military, civilian and contractor personnel at six hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has executed 4,697 contracts worth more than $2.6 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: afwerx.com.
Roboligent wins Air Force AFWERX STTR Phase I
Roboligent announces its selection by AFWERX for a Small Business Technology Transfer (STTR) Phase I award. This Phase I grant will give us the opportunity to explore how our rehabilitation robot can improve outcomes for military rehabilitation. AFWERX’s STTR program provides a launchpad for small businesses like ours to enter the U.S. Military market. Roboligent’s solution features a unique degrees of freedom (7 DOF) robot, offering force-controlled, dynamically interactive, and safe motion-based therapies in a full 6D motional space. This novel design automates physical therapy, helping patients with neuromuscular problems, injuries, or impairments regain essential strength, range of motion, and functionality. “We believe that our human-interactive rehabilitation robots will help improve the quality of care for the Air Force Medical Service,” said Roboligent’s CEO, Dr. Bongsu Kim. “By enabling upper and lower-body rehabilitation with a single rehabilitation robot, we will be able to significantly reduce costs and provide more effective treatment by helping patients learn their movement patterns and strength, adapt to their condition, and safely perform repetitive exercise therapy.” The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now Roboligent will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. “The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government.” About AFRL The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit afresearchlab.com. About AFWERX As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 325 military, civilian and contractor personnel at six hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has executed 4,697 contracts worth more than $2.6 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: afwerx.com.
Roboligent Joins Johnson & Johnson Innovation – JLABS
Roboligent, a company that leads the robot service automation market based on its hyper-precise force control technology, announced today that it has been selected as a resident company of Johnson & Johnson Innovation – JLABS @ TMC. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. Roboligent is seeking to accelerate the innovation of its first commercialized product, the Regen rehabilitation therapy automation robot. Regen is a rehabilitation therapy automation robot that helps patients with upper and lower limb rehabilitation needed due to stroke or other diseases by learning the patient’s movement patterns and strength, adapting to the patient’s condition, and safely performing repetitive exercise therapy. In addition, Regen can quantitatively evaluate the patient’s exercise ability, unlike the previous method in which a skilled therapist evaluated it in a qualitative way, and can increase the motivation for recovery by enabling tracking and observation of the patient’s exercise content and recovery process. Therefore, it has the advantage of being able to set a more systematic exercise therapy plan.
Showcase our robot on site in Texas Regional Robotics Symposium
Our team had the opportunity to showcase our rehabilitation robot to graduate students, researchers, and professors majoring in robotics at the Texas Regional Robotics Symposium (#TEROS) hosted by Rice University last week. We deeply appreciate their interest and support and thank TEROS for inviting us. https://teros-texas.github.io/ #TEROS #rehabilitationrobot #physicaltherapy #assistantrobot The University of Texas at Austin #mechanicalengineering #robotics #alumni
Why do we need force-controlled robots for rehabilitation?
The majority of current robots utilize position/velocity control technology, which limits patients’ voluntary movement efforts due to the nature of being restricted to repetitive, pre-determined kinematic patterns. Force control robots are designed to interact with humans in a safe and controlled manner. They use sophisticated sensors and control algorithms to adjust their force output based on the force feedback they receive from the environment. This allows them to exert the appropriate amount of force when interacting with people, while minimizing the risk of injury or damage. In the context of interacting with humans, force control robots can be used in a variety of applications, such as rehabilitation, physical therapy, and assistance with daily activities. For example, a force control robot can help a person recover from a stroke or other physical injury by providing targeted resistance training that is tailored to their specific needs. The robot can adjust its force output in real-time to ensure that the person is not being over-exerted or at risk of injury. Another important application of force control robots is in the field of prosthetics. With the use of sensors and control algorithms, prosthetic limbs can be designed to provide the appropriate amount of force for different tasks, such as grasping objects or walking. This can greatly enhance the mobility and independence of people with limb amputations, allowing them to perform daily activities with greater ease and confidence. In addition to their practical applications, force control robots can also have a significant impact on the relationship between humans and robots. By providing a safe and responsive interaction experience, force control robots can help to bridge the gap between humans and machines, fostering a greater sense of trust and acceptance. However, there are also challenges associated with the use of force control robots in interacting with humans. One of the major challenges is ensuring that the robots are able to respond quickly and accurately to the force feedback they receive from the environment. This requires sophisticated sensing and control algorithms, which can be difficult and expensive to develop. Another challenge is designing the robots to be intuitive and easy to use for people with different levels of physical ability and cognitive function. This requires careful consideration of factors such as the robot’s size, shape, and interface, as well as its overall behavior and communication style. Overall, force control robots have the potential to greatly enhance the safety, effectiveness, and acceptance of human-robot interactions. However, their development and deployment will require ongoing research and development, as well as careful consideration of ethical, social, and practical considerations.
Roboligent has joined the TMC Innovation Accelerator for HealthTech
Roboligent has joined the TMC Innovation Accelerator for HealthTech. We are very excited to be part of the TMCi Accelerator! The accelerator provides a unique opportunity for startups harnessing powerful technologies to continue to evolve their products and services while creating lasting relationships with Texas Medical Center (TMC) member institutions, advisors, and investors. TMC Innovation TMC Innovation is shaping the future of health care by uniting promising innovators with the best minds in science and medicine at the member institutions of the Texas Medical Center. OUR MISSION IS TO INCREASE THE QUALITY AND QUANTITY OF HEALTHCARE STARTUP DENSITY IN HOUSTON. Texas Medical Center Innovation forms, fosters, recruits, and funds healthcare companies from around the world that are writing the future of healthcare. In collaboration with key stakeholders from our TMC members as well as our global network of advisors and embedded corporate partners, we perform diligence on the companies seeking to progress toward clinical and business milestones. We align these resources through our globally recognized programs, our co-working space, and our corporate partners.
Showcase our robot on site in Texas Life Science Forum
Roboligent is delighted to participate in the Texas Life Science Forum to connect with the Health/MedTech community. We are excited to showcase our robot on site. The 10th Annual Conference will be held in person on February 24, 2022, at Rice University in Houston. For event information, visit https://txlifescienceforum.org/
Check out our Asian market affiliate!
HERE Life Science, our collaborator, has launched a new website! HERE focuses on the medical device business especially with our robot, Optimo Regen. Many Asian countries are confronting the hardships of aging societies. One of the main concerns is how to maintain the quality of healthy life of the aged population under clinical resource shortages. For example, many hospitals and clinics in Singapore are looking for new automation solutions to maximize the time usage of physical therapy sessions. We believe Optimo Regen will be a perfect solution to the problem and customers agree, as HERE already starts to engage with some leading hospitals and therapists. Invest today and be part of the journey!
We are accepting investments now!
Click here: https://www.startengine.com/roboligent
LinkDyn Robotics wins the NSF TECP grant
Big congratulations to our team! We have been awarded a Technology Enhancement for Commercial Partnerships (TECP) program grant from the National Science Foundation. This program provides a supplement of up to $150,000 to current SBIR or STTR awardees in order to pave the way for partnerships between strategic corporate partners and investors. https://seedfund.nsf.gov/resources/awardees/supplement/commercial/ https://www.nsf.gov/pubs/2013/nsf13132/nsf13132.jsp